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Respiratory tract infections with viruses and Pasteurella spp. were determined sequentially among 26 cattle
that died during two severe epizootics of shipping fever pneumonia. Nasal swab and serum samples were
collected prior to onset of the epizootics, during disease progression, and after death, when necropsies were
performed and lung samples were collected. Eighteen normal control cattle also were sampled at the beginning
of the epizootics as well as at weekly intervals for 4 weeks. Respiratory bovine coronaviruses (RBCV) were
isolated from nasal secretions of 21 and 25 cattle before and after transport. Two and 17 cattle nasally shed
Pasteurella spp. before and after transport, respectively. RBCV were isolated at titers of 1 3 103 to 1.2 3 107
PFU per g of lung tissue from 18 cattle that died within 7 days of the epizootics, but not from the lungs of the
remaining cattle that died on days 9 to 36. Twenty-five of the 26 lung samples were positive for Pasteurella spp.,
and their CFU ranged between 4.0 3 105 and 2.3 3 109 per g. Acute and subacute exudative, necrotizing lobar
pneumonia characterized the lung lesions of these cattle with a majority of pneumonic lung lobes exhibiting
fibronecrotic and exudative changes typical of pneumonic pasteurellosis, but other lung lobules had histolog-
ical changes consisting of bronchiolitis and alveolitis typical of virus-induced changes. These cattle were
immunologically naive to both infectious agents at the onset of the epizootics, but those that died after day 7
had rising antibody titers against RBCV and Pasteurella haemolytica. In contrast, the 18 clinically normal and
RBCV isolation-negative cattle had high hemagglutinin inhibition antibody titers to RBCV from the beginning,
while their antibody responses to P. haemolytica antigens were delayed. Evans’ criteria for causation were
applied to our findings because of the multifactorial nature of shipping fever pneumonia. This analysis
identified RBCV as the primary inciting cause in these two epizootics. These viruses were previously not
recognized as a causative agent in this complex respiratory tract disease of cattle.
Shipping fever pneumonia (SFP) occurs frequently among
cattle after transport and is characterized by fever, dyspnea,
and exudative inflammatory and necrotizing lung lesions (11,
37). This form of pneumonia affected 64% of fatal cases in a
study of feedlot cattle in Colorado (17). A multifactorial etio-
logical concept for SFP is widely accepted in scientific circles,
which implies that crowding and other stressful conditions
favor virus spread and infections of respiratory tracts that be-
come complicated with Pasteurella and other bacterial infec-
tions, often leading to fatal pneumonia (13, 37). Losses from
SFP continue to occur in spite of widespread use of modern
management and vaccination programs derived from decades
of intensive research on physiological factors, infectious agents
and pathogenesis of respiratory tract diseases, defense mech-
anisms and immune responses of cattle, modern vaccines,
metaphylactic and therapeutic antibiotic treatments, and im-
proved diagnostic tools (30, 37).
Viruses currently considered as potential etiological factors
of SFP include bovine herpesvirus-1 (BHV-1) of infectious
bovine rhinotracheitis (18, 23, 37), bovine parainfluenza type-3
virus (PI-3) (2, 26, 27), bovine respiratory syncytial virus
(BRSV) (5, 36, 37), and bovine viral diarrhea virus (BVDV)
(25, 37). Respiratory tract samples yielded BHV-1 and no
other viruses in 18% of 354 fatal cases of SFP in an investiga-
tion reported by Jensen and coworkers (17). Isolations of
BHV-1 were made from nasal or eye secretions and tracheal
samples, but rarely from affected lungs (17, 18, 24). Infections
with PI-3 were detected sporadically in lungs of field cases of
SFP (26, 37). The direct involvement of BRSV or BVDV in
naturally occurring epizootics of SFP has not been docu-
mented in published reports (37). Experimental exposure of
calves to BRSV induced respiratory distress (5, 36), but this
virus was reisolated only from nasal swab samples, and bacte-
rial infections were detected in the lungs of 8 of 12 experimen-
tal animals (36). Sequential inoculations of cattle with BHV-1,
PI-3, or BVDV and Pasteurella haemolytica induced more se-
vere signs of clinical disease than the single infections (2, 18,
25, 27). Bacterial insults in SFP are P. haemolytica or Pasteu-
rella multocida as well as Haemophilus somnus infections (4, 6,
14, 35).
Respiratory bovine coronaviruses (RBCV) were first iso-
lated in 1993, and they were identified as emerging respiratory
tract infections of cattle after transport to feed yards (28).
Infections with RBCV had not been considered in the past as
an etiological factor in SFP of cattle (37). High rates of primary
respiratory tract infections with this virus and secondary infec-
tions with Pasteurella spp. among 105 and 120 cattle during two
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severe SFP epizootics were reported (21, 30). The objectives of
the current investigations were to examine nasal shedding of
viruses and P. haemolytica or P. multocida during the patho-
genesis of fatal SFP among 26 cattle under experimentally
designed conditions, to quantitate the infectious loads of these
viruses and bacteria in the lungs, to relate these infections to
the pneumonic lung lesions, to compare antibody responses to
RBCV and P. haemolytica between fatal cases and clinically
normal control cattle that remained RBCV isolation negative
during these epizootics, and to analyze the etiological roles of
the newly emerging RBCV infections according to Evans’ cri-
teria for causation (7).
MATERIALS AND METHODS
Experimental design. Ten of 105 and 16 of 120 cattle of two SFP epizootics
occurring in 1997 and 1998 (97TXSF and 98TXSF, respectively) were subjected
to prospective, experimentally designed sampling and testing at the time of
assembly (day 0), after transport (day 5), and throughout the pathogenesis of
fatal pneumonia. The cattle were ear-tagged and clinically examined at assembly,
when initial sets of nasal swab samples for culture of infectious agents and blood
samples for serum harvest were collected. Nasal swab samples were placed into
transport medium for virus isolation, while dry samples were used for bacterial
cultures. Nasal swab samples were placed on dry ice and subsequently trans-
ferred into 270°C freezers. All cattle were vaccinated with modified-live virus
vaccines against BHV-1 and PI-3 in 1997, and only against BHV-1 in 1998
(Prevail and Reliant; Rhone Merieux, Inc., Athens, Ga.). The experimental
calves also were given blackleg vaccines (Electroid 7; Mallinckrodt Vet. Inc.,
Mundelein, Ill.) and ivermectin (Ivomec; Merck and Co., Inc., Rahway, N.J.).
They remained for 4 days at the assembly site of the order buyer and then were
transported 1,932 km to the feed yard in Bushland, Tex., jointly operated by the
Agricultural Research Service and the Texas Agricultural Experiment Station.
They were clinically examined on the day of arrival in the feed yard (day 5) and
daily thereafter. Nasal swab and blood samples also were taken at this time and
subsequently on a weekly schedule. Seven and 11 cattle of the respective epizoot-
ics remained clinically normal and were also tested microbiologically and sero-
logically as contact controls.
Necropsies, pathological, histopathological, and immunocytochemical exam-
inations. Necropsies were performed immediately after death, and lung samples
were collected at the Texas Veterinary Diagnostic Laboratory in Amarillo, Tex.
Aliquots of the lung samples were frozen at 270°C for isolation, identification,
and quantification of viruses and bacteria. Pieces from each lung were used to
make exfoliative cytological or cryostat preparations for immunofluorescent tests
with antibodies specific for RBCV and BVDV. Lung tissue pieces were placed
into neutral 10% phosphate-buffered formalin for fixation. Histological sections
were prepared and stained by the hematoxylin-eosin methods.
Bacterial isolation, identification, and quantification. Dry nasal swab samples
were removed from the freezer and allowed to thaw at 25°C. Each swab was
streaked over one-fourth of the surface of a plate. The lung specimens were
thawed, the surfaces were seared with a hot spatula, and a 1-g sample was
removed from the center of each specimen. Lung tissues were minced with
scissors and homogenized in phosphate-buffered saline (PBS) at pH 7.4 by
grinding with a Ten Broeck device. The resulting 10% (wt/vol) suspension was
serially diluted in 10-fold steps. Aliquots of 0.1 ml of the dilutions were plated in
five replicas on tryptose agar plates fortified with 5% citrated bovine blood to
enumerate CFU. The culture plates were incubated at 37°C for 24 h in an
atmosphere with 5% CO2. Bacterial colonies were counted, and their numbers
on each replica were averaged. Colonies of P. haemolytica and P. multocida were
identified by colony morphology, Gram staining, and biochemical reactions and
by use of specific antisera for serotyping P. haemolytica isolates (8, 9, 34).
Preparation of clinical samples for virus isolation. The nasal swab samples
were thawed at 25°C, and 1 ml of cold Dulbecco’s modified minimum essential
medium (DMEM) was added to each tube. Aliquots of these fluids were cen-
trifuged at 2,000 3 g (model TJ-6R; Beckman Instruments, Inc., Palo Alto,
Calif.) for 20 min. Supernatant fluids were withdrawn and filtered through
Millipore filters (Gelman Sciences, Ann Arbor, Mich.) with a pore size of 0.450
mm. The filtrates were then used to inoculate the cell cultures. Lung tissues were
minced and homogenized by grinding with Ten Broeck devices in the appropriate
volume of cold DMEM to make 5% (wt/vol) suspensions. The lung homogenates
were centrifuged at 2,000 3 g. The top half of the supernatant was withdrawn,
diluted 1:1 with cold DMEM, and subjected to a 2nd cycle of centrifugation. The
top half of this supernatant was withdrawn, filtered as indicated, and used for
virus isolation tests or RBCV infectivity titration (28, 30).
Virus isolation methods. Specific virus isolation tests depended on three dif-
ferent cell types selectively permissive for the known respiratory bovine viruses.
Cell cultures included the G clone of human rectal tumor-18 (HRT-18) cells
specifically permissive for RBCV (19, 28, 33), Georgia bovine kidney (GBK) cells
permissive for BHV-1, PI-3, and bovine adenoviruses (BAV), as well as bovine
turbinate (BT) cells highly permissive for BRSV and cytopathogenic BVDV,
and, to a lesser degree, permissive for BHV-1, PI-3, and BAV (28). These cell
types were propagated in 24-well cluster plates (Becton-Dickinson Labware,
Franklin Lakes, N.J.) and used in virus isolation tests by inoculating four wells:
two of them with 1021 and two with 1022 dilutions of each test sample. Cells in
four wells remained as uninoculated cell controls for each test plate. The inoc-
ulated cell cultures were incubated at 37°C and examined for cytopathic changes
with an inverted microscope for 2 to 5 days. The cell cultures then were frozen
at 270°C and thawed at 25°C. Cultures with cytopathic changes after inoculation
with specific samples were pooled, and those remaining normal were also pooled
as single samples for subpassages in the respective permissive cell cultures and
for detecting hemagglutinin (HA) or receptor-destroying enzyme (RDE) activ-
ities (28, 31).
Identification of virus isolates. The virus isolates were initially differentiated
by characteristics of cytopathic effects in the specifically permissive cell types.
Additional virus identification tests included HA detection with rat erythrocytes
(RBC) and assays for RDE functions mediated by acetylesterase (AE), a char-
acteristic of RBCV. Tests for HA of PI-3 involved the use of bovine and chicken
RBC. Virus isolates were further identified by using specific antisera in HA
inhibition (HAI), infectivity neutralization tests, or negative-contrast staining
and electron microscopic examinations (28).
Quantification of RBCV in the infected lung tissues. The plaque test was used
to assess the titers of PFU of RBCV in 25 available lung samples according to
recently described procedures (19). The lung samples prepared for virus isola-
tions were serially diluted in 10-fold steps, and 0.5-ml aliquots of the respective
dilutions were placed on confluent G clone cell monolayers grown in six-well
cluster plates. (Becton-Dickinson Labware, Franklin Lakes, N.J.). The plaque
test for PI-3 infectivity involved GBK cell cultures and was otherwise identical.
The plaque test for BHV-1 employed GBK cell cultures, a 2% methylcellulose
overlay, and crystal violet staining.
Tests for viral HA and RDE. Washed rat RBC at a concentration of 0.5% in
PBS at pH 7.4 containing 0.05% bovine serum albumin (BSA) were used to
detect HA antigens of RBCV in infected G clone cultures. The same concen-
trations of bovine or chicken RBC were used to detect HA of PI-3 isolates.
Twofold dilutions of 50 ml of the samples were made in 96-well V-bottom
microtiter plates (Becton Dickinson Labware, Franklin Lakes, N.J.), and equal
volumes of RBC suspensions were added to each well (31). The plates were
shaken and incubated at 6°C for 2 h, which is sufficient time for the RBC to form
clear buttons in diluent control wells. The HA titers were recorded as the highest
dilution with complete agglutination of RBC suspensions. The plates were then
incubated at 37°C for activation of the RDE function. The RDE titer was
determined by elution of virus from rat RBC in wells with previous agglutination
and was recorded after 2 h as the highest dilution with settled RBC (31).
HAI tests. Sequentially serum samples from the 26 cattle with fatal pneumonia
and from 18 normal control cattle were tested for HAI antibodies against RBCV
antigen. These sera were also tested for antibodies against P. haemolytica antigen
in an enzyme-linked immunosorbent assay (ELISA). The serum samples were
diluted 1:4 in PBS containing 0.05% BSA, heat-inactivated at 56°C for 30 min,
and then diluted in twofold steps in 50-ml aliquots. An antigen extracted from
RBCV-infected cell lysates was used and diluted to contain 8 to 16 U of HA and
RDE. The antigen was added in 50-ml volumes to each serum dilution. The
serum-antigen mixtures reacted for 30 min at 25°C, and 50 ml of rat RBC
suspensions then was added. The test plates were kept at 6°C for 2 h, and the
HAI titers were determined as the highest dilutions inhibiting HA of RBCV.
Serum 1745 with a known HAI antibody titer and normal serum were included
as positive and negative controls, respectively.
Determination of P. haemolytica antibodies. A 32-kDa outer membrane pro-
tein of P. haemolytica was harvested from 18- to 24-h cultures in beef heart
infusion broth as the supernatant after a 10,000 3 g centrifugation. The antigen
preparation was diluted 1:12.5, test sera were diluted 1:50, and the ELISA was
performed as described previously (3).
RESULTS
Shedding of RBCV and Pasteurella spp. in nasal secretions
before death. Virus and bacterial isolation results from nasal
swab samples of the 26 fatal cases from the two epizootics are
recorded in Table 1. In the 1997 experiment, six cattle shed G
clone-dependent RBCV in nasal secretions on day 0, and three
additional calves contracted this infection on day 5. In the 1998
experiment, 15 of the 16 cattle shed RBCV at the beginning of
the experiment, and all of them did so on day 5. Other viruses
were not isolated from nasal discharges of these 26 cattle
during the first 5 days of the experiments. Three cattle, surviv-
ing 14 to 36 days after onset of this epizootic, began shedding
BHV-1 on day 12 and PI-3 on day 26 (data not shown). Calf
98TXSF-115 had a dual infection with RBCV and BHV-1 on
day 12, and calves 98TXSF-15 and 98TXSF-100 nasally shed
BHV-1 on days 12 and 19. Calf 98TXSF-15 nasally shed
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BHV-1 and PI-3 on day 26 (data not shown). Calf 98TXSF-100
was nasally BHV-1 isolation negative on day 26, and became
PI-3 isolation positive on day 33 (data not shown). Uninocu-
lated cell culture controls maintained normal morphological
features in all of these virus isolation tests. Two of the 26 cattle
shed P. haemolytica on day 0, and 17 of them carried P. hae-
molytica after transport on day 5. The 18 normal control cattle
did not secrete RBCV in their nasal discharges during the test
periods (30). None of the 18 normal control cattle had Pasteu-
rella spp. in nasal swabs on day 0, and 3 of them nasally shed P.
haemolytica on day 5 (data not shown).
Combined lung infections with RBCV and Pasteurella spp.
and respective titers in the 1997 and 1998 epizootics. Pneu-
monic lung samples from 9 of 10 cattle of the 1997 experiment,
and from 9 of 16 cattle of the 1998 experiment were RBCV
isolation positive when they died between days 5 and 7 (Table
2). The RBCV titers ranged from 1 3 103 to 1.2 3 107 PFU per
g of lung tissues. BHV-1 was detected at 2 3 103 PFU per g of
lung tissue of calf 98TXSF-115, which died on day 14. Less
than 103 PFU of PI-3 per g of lung tissue were detected in
calves 98TXSF15 and 98TXSF-100, which died on days 31 and
36, respectively. The last calf had the most drawn-out respira-
tory tract disease and was treated with antibiotics six times at
different intervals. The lung of calf 98TXSF-114 was not avail-
able for virological testing. The 25 available lung tissues of 26
dead cattle tested did not yield BRSV, cytopathogenic BVDV,
or BAV through inoculation of selectively permissive cell cul-
ture systems. Cells of the exfoliative or cryostat preparations
from these lungs did not react with BVDV-specific fluorescent
antibodies. This test was included to detect the potential pres-
ence of noncytocidal BVDV in these lungs.
P. haemolytica was cultured from the lungs of all 10 calves
which died in the 1997 epizootic, as indicated in Table 2. Calf
97TXSF-15 had a pure culture of P. haemolytica A6. The lungs
of the other nine calves had P. haemolytica A1 infections, and
calf 97TXSF-52 also had P. multocida infections. Pasteurella
spp. were isolated from 15 lungs of 16 calves which died in the
1998 epizootic (Table 2). Four calves (98TXSF-10, -71, -72,
and -91) had mixed infections of P. haemolytica A1 and P.
multocida. Calves 98TXSF-14, -36, -85, -100, and -110 had pure
P. multocida infections of the lungs. The bacterial isolate from
the lung of calf 98TXSF-102 was identified as a pure culture of
P. haemolytica A2, while the bacterial isolates from the remain-
ing five calves were identified as pure P. haemolytica A1. The
lungs of calf 98TXSF-15 that died at the end of the study after
repeated treatment with antibiotics were negative in bacterial
cultures. The CFU of P. haemolytica varied from 4 3 105 to
1.4 3 109 per g of lung tissue. The CFU of P. multocida ranged
from 6.0 3 105 to 2.3 3 109 per g of lung tissue.
Biological properties of the virus isolates. The RBCV iso-
lated from the pneumonic lungs were indistinguishable from
the isolates detected in sequential nasal swab samples. These
RBCV isolates exhibited high fusogenic functions in G clone
cells in the first passage, did not replicate in GBK or BT cells,
and agglutinated rat but not bovine or chicken RBC. All
RBCV isolates destroyed rat RBC glycoconjugate receptors as
a function of their RDE. Uniformly large RBCV plaque phe-
notypes with diameters of 5 to 6 mm were detected in the
plaque titration of the pneumonic lungs of cattle in the 1997
and 1998 epizootics (data not shown). The viruses isolated by
inoculation of GBK or BT cell cultures were identified as
BHV-1 through their cytopathic changes consisting of clusters
of rounded cells and neutralization by BHV-1-specific anti-
serum. They were not temperature sensitive like some com-
TABLE 1. Isolation of viruses and Pasteurella spp. from nasal secretions of cattle with fatal SFP in the 1997 and 1998 epizootics
Calf Day ofdeath
Isolation of agent on daya:
RBCV Pasteurella spp.
0 5 12 19 0 5 12 19
97TXSF-52 5 2 1 2 2
97TXSF-5 6 1 1 2 2
97TXSF-15 6 1 1 2 2
97TXSF-19 6 1 1 2 A1b
97TXSF-43 6 1 1 2 2
97TXSF-62 6 2 1 A1 2
97TXSF-75 6 2 1 2 A1
97TXSF-96 6 1 1 2 2
97TXSF-58 7 1 1 2 2
97TXSF-63 9 2 2 2 2
98TXSF-85 5 2 1 2 A1
98TXSF-10 6 1 1 2 A1
98TXSF-11 6 1 1 2 A1
98TXSF-14 6 1 1 2 A1
98TXSF-91 6 1 1 2 A1
98TXSF-110 6 1 1 2 A1
98TXSF-71 7 1 1 2 A1
98TXSF-72 7 1 1 2 A1
98TXSF-106 7 1 1 2 A1
98TXSF-114 7 1 1 2 A1
98TXSF-102 12 1 1 2 A1
98TXSF-104 13 1 1 2 2 2 2
98TXSF-115 14 1 1 1/BHV-1 2 A1 A1
98TXSF-36 27 1 1 2 2 2 A1 2 2
98TXSF-15 31 1 1 2/BHV-1 2/BHV-1 2 A1 2 2
98TXSF-100 36 1 1 2/BHV-1 2/BHV-1 A1 A1 2 2
a 2, RBCV or Pasteurella spp. not isolated; 1, RBCV isolated.
b A1, P. haemolytica type A1.
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mercial live BHV-1 vaccines because they multiplied at 36 and
39°C. The virus isolates from the lungs of calves 98TXSF-15
and 98TXSF-100 induced cell fusion in GBK or BT cells and
agglutinated chicken and bovine RBC, and their HA was in-
hibited by PI-3-specific antiserum. These properties identified
these isolates as PI-3.
Antibody responses to infections with RBCV and P. haemo-
lytica of cattle developing fatal pneumonia and healthy resis-
tant cattle. The dead cattle of both epizootics had HAI anti-
body titers of ,8 to 16 on day 0, with the exception of calf
97TXSF-63. These titers remained at these low levels during
the first 5 days (Table 3). The HAI antibody titers of calf
97TXSF-63 that died on day 9 was 32 on day 0 and increased
to 256 on day 5. Both nasal swab and lung samples from this
calf remained negative for virus isolation. The three cattle of
the 1998 experiment that died between days 27 and 36 had
increasing HAI titers reaching 64. Isolation of RBCV from
lung tissues of these cattle was unsuccessful. The ELISA re-
sults indicated that all except one calf were antibody negative
for P. haemolytica antigen on day 0, and the antibody levels
rose among 10 of 18 cattle that were tested on day 5 (Table 3).
The four cattle that died between days 14 and 36 maintained
such titers.
The HAI antibody titers of the 18 normal control cattle that
remained clinically healthy and did not nasally shed RBCV in
the 1997 and 1998 experiments ranged from 16 to 1,024 on day
0 (Table 4). Their antibody titers continued to rise and re-
mained high on days 12 and 19. Ten of the 18 cattle were
antibody negative for P. haemolytica antigen on day 0, 16 had
positive titers on day 5, and all had significant titers on days 12
and 19.
Clinical and pathological findings. Ten of 105 cattle in the
1997 experiment died on days 5 to 9, and 16 of 120 cattle in the
1998 epizootic died on days 5 to 36 (Tables 1 and 2). They all
developed fever as high as 44°C and severe signs of respiratory
distress. The necropsy examinations revealed that 50 to 80% of
the total lung volumes had subacute exudative or subacute
exudative and necrotizing lobar pneumonia primarily affecting
the anteroventral areas of the lungs. The exudative component
of the pneumonic process consisted of fibrin deposited to var-
ious degrees on the pleural surfaces of lungs or within dis-
tended intralobular septae and airways. Gross lesions in the
gastrointestinal tracts or other organ systems of these cattle
were not detected. All cattle were treated under good nutri-
tional conditions.
Histological changes. The microscopic changes in a majority
of the pneumonic lung lobules were characterized as acute and
subacute fibrinous bronchopneumonia. Typical exudative le-
sions associated with pneumonic pasteurellosis were not evi-
dent in isolated lung lobules. These lobules had moderate to
severe bronchitis and bronchiolitis consisting of degenerating
and necrotic respiratory epithelium with subepithelial and
intraepithelial, nonsuppurative inflammatory cell infiltration
(Fig. 1). Hyperchromatic and fused epithelial cells were present in
airway epithelium adjacent to areas of necrosis, degeneration,
and intraepithelial inflammation. These changes were detected
at all levels of the lower respiratory tract from small bronchi to
alveolar ducts. Many alveoli were no longer lined by type I
pneumocytes and were partially filled with pink, protein-rich
exudates and mixtures of small and large mononuclear leuko-
cytes. Intracytoplasmic or intranuclear inclusions were not dis-
cernable. Cytoplasmic fluorescence was detected in epithelial
cells of bronchi, broncheoli, and alveolar ducts when cryostat
sections of the lungs of cattle that died within 7 days were
tested with fluorescing antibodies against RBCV (data not
shown). Cells of these lung sections did not fluoresce when
TABLE 2. Titers of viruses and Pasteurella spp. in lungs of cattle with fatal SFP in the 1997 and 1998 epizootics
Calf Day ofdeath
Titer ofa:
Virus (PFU/g) Pasteurella spp. (CFU/g)
97TXSF-52 5 RBCV, 5.0 3 106 A1, 1.0 3 106; P. multocida, 1.6 3 107
97TXSF-5 6 RBCV, 1.2 3 105 A1, 7.0 3 108
97TXSF-15 6 RBCV, 3.0 3 106 A6, 4.8 3 108
97TXSF-19 6 RBCV, 8.0 3 104 A1, 1.4 3 109
97TXSF-43 6 RBCV, 8.0 3 103 A1, 3.4 3 108
97TXSF-62 6 RBCV, 1.0 3 105 A1, 8.2 3 108
97TXSF-75 6 RBCV, 1.4 3 106 A1, 1.5 3 107
97TXSF-96 6 RBCV, 3.4 3 106 A1, 1.1 3 107
97TXSF-58 7 RBCV, 2.0 3 105 A1, 1.9 3 106
97TXSF-63 9 A1, 2.8 3 106
98TXSF-85 5 RBCV, 6.0 3 104 P. multocida, 6.0 3 105
98TXSF-10 6 RBCV, 1.0 3 105 A1, 3.3 3 108; P. multocida, 2.5 3 106
98TXSF-11 6 RBCV, 6.0 3 106 A1, 6.3 3 108
98TXSF-14 6 RBCV, 1.0 3 103 P. multocida, 2.4 3 108
98TXSF-91 6 RBCV, 1.2 3 107 A1, 4.0 3 107; P. multocida, 1.4 3 108
98TXSF-110 6 RBCV, 2.4 3 106 P. multocida, 2.3 3 109
98TXSF-71 7 RBCV, 4.0 3 105 A1, 3.0 3 108; P. multocida, 4.1 3 108
98TXSF-72 7 RBCV, 2.0 3 104 A1, 3.1 3 108; P. multocida, 2.1 3 108
98TXSF-106 7 RBCV, 2.0 3 104 A1, 2.5 3 106
98TXSF-114 7 NAb A1, 8.0 3 106
98TXSF-102 12 A2, 9.5 3 105
98TXSF-104 13 A1, 2.9 3 106
98TXSF-115 14 BHV-1, 2.0 3 103 A1, 4.0 3 105
98TXSF-36 27 P. multocida, 1.1 3 108
98TXSF-15 31 PI-3, ,1.0 3 103
98TXSF-100 36 PI-3, ,1.0 3 103 P. multocida, 7.5 3 107
a A1, -2, and -6, P. haemolytica types A1, -2, and -6.
b NA, not available.
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treated with RBCV antibody-negative serum or with BVDV
antiserum.
DISCUSSION
The prospective experimental designs of our investigations
permitted sequential tracing of shedding of viruses and bacte-
ria in nasal discharges during the naturally occurring course of
fatal SFP pathogenesis. Virtual experimental induction of SFP
thus was monitored through clinical, virological, bacteriologi-
cal, serological, and pathological evaluations. Epizootics of
SFP had not been explored in the past by such approaches
(37). Significantly, 25 of 26 calves that died profusely shed
RBCV in nasal secretions during the early phases of the two
epizootics of SFP. In addition, this previously not recognized
RBCV infection was present in the lungs of all cattle that died
between days 5 and 7 of the experiments. However, RBCV was
TABLE 3. Antibody responses to RBCV and P. haemolytica of cattle with fatal SFP in the 1997 and 1998 epizootics
Calf Day ofdeath
HAI titer to RBCV on daya: Antibody titer to P. haemolytica on dayb:
0 5 12 19 0 5 12 19
97TXSF-52 5 8 8 0 0
97TXSF-5 6 8 16 0 184
97TXSF-15 6 16 NAc 0 NA
97TXSF-19 6 16 NA 0 NA
97TXSF-43 6 8 NA 0 NA
97TXSF-62 6 8 16 0 0
97TXSF-75 6 16 16 0 491
97TXSF-96 6 16 16 0 0
97TXSF-58 7 16 16 0 0
97TXSF-63 9 32 256 0 445
98TXSF-85 5 8 NA 0 NA
98TXSF-10 6 ,8 NA 0 NA
98TXSF-11 6 8 NA 0 NA
98TXSF-14 6 8 8 0 0
98TXSF-91 6 8 NA 0 NA
98TXSF-110 6 8 NA 0 NA
98TXSF-71 7 8 16 0 583
98TXSF-72 7 8 16 48 253
98TXSF-106 7 ,8 8 0 0
98TXSF-114 7 ,8 8 0 0
98TXSF-102 12 ,8 16 0 105
98TXSF-104 13 ,8 ,8 NA 396 399 NA
98TXSF-115 14 8 8 8 0 299 442
98TXSF-36 27 16 16 64 64 0 522 396 173
98TXSF-15 31 8 16 32 64 0 563 698 668
98TXSF-100 36 ,8 8 32 64 0 0 593 102
a An 8 indicates a titer with complete inhibition of RBCV HA.
b A 0 indicates no antibody reaction in ELISA.
c NA, not available.
TABLE 4. Antibody responses to RBCV and Pasteurella spp. of resistant cattle in the 1997 and 1998 epizootics of SFP
Cow
HAI titer to RBCV on daya: Antibody titer to P. haemolytica on dayb:
0 5 12 19 0 5 12 19
97TXSF-2 256 256 256 128 640 549 897 708
97TXSF-4 16 512 1,024 256 0 606 904 844
97TXSF-9 32 512 512 256 0 716 674 843
97TXSF-29 16 256 512 256 315 485 599 967
97TXSF-32 64 512 512 256 0 418 675 609
97TXSF-41 128 256 512 256 0 702 818 702
97TXSF-55 64 256 512 512 177 330 463 679
98TXSF-2 16 16 64 256 705 516 690 572
98TXSF-27 128 256 256 256 0 607 834 710
98TXSF-30 64 1,024 1,024 1,024 0 0 613 532
98TXSF-32 128 128 128 128 0 532 762 833
98TXSF-34 512 512 512 256 54 115 338 251
98TXSF-44 16 64 512 256 0 0 103 519
98TXSF-47 256 256 1,024 1,024 478 447 466 429
98TXSF-52 64 256 256 512 462 504 464 465
98TXSF-93 1,024 1,024 256 256 0 487 492 515
98TXSF-94 256 256 256 512 0 170 625 636
98TXSF-119 128 128 128 128 452 732 625 708
a A 256 indicates a titer with complete inhibition of RBCV HA.
b A 0 indicates no antibody reaction in ELISA.
VOL. 38, 2000 CORONAVIRUS AND PASTEURELLA IN SHIPPING FEVER PNEUMONIA 3295
 o
n
 Septem
ber 12, 2018 by guest
http://jcm.asm.org/
D
ow
nloaded from
 
not isolated from the lungs of calves dying on days 9 to 36, most
of which had significant HAI antibody titers when they died.
Large RBCV plaque phenotypes with titers reaching 1.2 3 107
PFU per g of tissue were detected in the lungs. Simultaneously,
the lungs from 25 of 26 cattle had infections with Pasteurella
spp. ranging in titers between 4 3 105 and 2.3 3 109 CFU per
g of lung tissue. Importantly, shedding of these bacteria in
nasal secretions was low at the beginning of the experiments
when RBCV was shed abundantly in nasal discharge. Clinically
normal control cattle or cattle with chronic lung worm infec-
tions did not shed RBCV in this and other related investiga-
tions (29, 30).
Histological changes consisted of lung lobules typical of vi-
rus infections and lung lobules with fibronecrotic pneumonia.
Similar sequential infectious interplays were reported in hu-
man subjects suffering from dual infections with influenza virus
of type A and Staphylococcus, Haemophilus, or Streptococcus
spp. and in experimentally induced, combined virus and bac-
terial infections of mice, swine, and cattle (15, 16). The upper
respiratory tracts but not lungs of clinically normal cattle may
harbor Pasteurella spp. and other bacteria (9–11, 14, 22). Bac-
terial invasion and multiplication in the lungs are associated
with pathogenic processes of SFP (6, 14, 35, 37). These data
substantiate our hypothesis that RBCV infections are caus-
atively associated with these epizootics of SFP.
The RBCV isolated from nasal swab and lung samples ex-
pressed RDE functions mediated by an AE that hydrolyzes an
ester bond to liberate acetate from sialic acid-containing bo-
vine submaxillary mucin, a substance with a chemical com-
position resembling the glycocalyx that covers the bovine re-
spiratory tracts (12, 31). Pathogenetic mechanisms probably
involved action of this viral enzyme by inducing glycocalyx
changes that lowered mucosal resistance barriers and favored
virus penetration and adhesion of P. haemolytica or P. multo-
cida to cells of the lower respiratory tracts.
Our refined virus isolation tests permitted the exclusion of
other respiratory bovine viruses that could have infected the
cattle during the initial stages of SFP pathogenesis (28, 30).
Immunofluorescence tests for noncytocidal BVDV infections
were negative when lung samples were tested with BVDV-
specific antibodies. Cytopathogenic BVDV, BRSV, or BAV
were not detected in nasal secretions or lungs through virus
isolation attempts with GBK and BT cell cultures (28). Three
calves that died on days 14, 31, and 36 with protracted pneu-
monia nasally shed BHV-1 or PI-3 late in the 1998 epizootic.
All of these cattle had initial respiratory tract infections with
RBCV on days 0 and 5 and had been given BHV-1 vaccines.
Numerous past attempts at inducing SFP have not repro-
duced the naturally occurring disease with shipping stress
alone; with experimental aerosol inoculation of BHV-1, PI-3,
or BRSV alone; or with bacterial aerosol exposure alone, un-
less large quantities of P. haemolytica organisms were intro-
duced directly into the lungs (5, 11, 24, 36, 37). Investigations
of sequential infections with these viruses and P. haemolytica
were also reported (2, 18, 25, 27, 37). More severe clinical signs
were observed in experiments with combined infections than
with single infections. The loads of the infectious components
in the lungs of experimental cattle were not assessed in any of
these investigations. While these types of experiments induced
respiratory tract diseases, they did not have the typical features
of naturally occurring SFP. The concept of SFP resulting from
the interplay of multifactorial burdens on respiratory health of
cattle is widely accepted (13, 32, 37). Stress readily is generated
at weaning, in auction markets, during transport, and with
adjustment to the feed yard environments. These conditions
also facilitate rapid spread of viral and bacterial infections.
The etiological roles of infectious agents and their mecha-
nisms of pathogenesis in SFP have been researched in numer-
ous past investigations, but they must still be further defined.
The original Henle-Koch’s postulates have not been proven for
a disease as complex as SFP (32, 37). Evans analyzed similar
challenges involving the roles of viruses in the genesis of
chronic diseases, several forms of cancer, or other complex
human disease conditions (7). He formulated a unified concept
of criteria for causation in order to identify specific etiological
factors in the genesis of complex and chronic diseases. Thom-
son first related these criteria for causation to infections lead-
ing to SFP (32).
Criteria for the involvement of different infectious factors in
SFP were evaluated by us according to Thomson’s ideas about
Evans’ criteria (7, 32). The potential etiological roles of RBCV
or other respiratory bovine viruses as causative factors in the
pathogenesis of the 1997 and 1998 epizootics of SFP were
applied to the following criteria. (i) The virus infects the mu-
cosa of respiratory tract passages and lungs of affected cattle.
(ii) The virus can be isolated in cell cultures at high rates from
respiratory secretions and lung samples during the pathogen-
esis of SFP. Both of these criteria were proven by the results of
FIG. 1. Photomicrographs of initial histological changes in lung from calf
98TXSF-11. (a) Small bronchus revealing respiratory epithelium degeneration
and necrosis with subepithelial and intraepithelial mononuclear inflammatory
infiltrates. (Inset) A single arrowhead identifies the margin of normal ciliated
epithelium; connected arrowheads mark epithelial degeneration and necrosis
with intraepithelial inflammation. The inset is a magnification of the area boxed
at the top of the panel. (b) Respiratory bronchiole and alveolar duct demon-
strating epithelial cell degeneration and necrosis. Asterisks identify areas of
mononuclear cell infiltration in and adjacent to respiratory epithelium and alve-
olar walls. The infectious load in this lung was 6 3 106 PFU of RBCV per g and
6.3 3 108 CFU of P. haemolytica A1 per g.
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investigations described in this and related reports (28, 30).
(iii) Virus-specific immune responses are observed in cattle
that recover from SFP. Rising titers of HAI antibodies against
RBCV were detected in all surviving calves which had RBCV
infections on days 0, 5, and later (data not shown). They de-
veloped typical primary antibody responses to RBCV infec-
tions characterized by increases in immunoglobulin M (IgM)
appearing first, followed by rises in IgG1 and IgG2 (20, 21, 30).
In contrast, the RBCV isolation-positive cattle with fatal out-
comes had no or low titers of HAI antibodies against RBCV in
the early stages of the epizootics. These cattle developed only
initial IgM responses to RBCV infections before they died (20,
21). (iv) Viruses isolated from cattle with SFP are not isolated
from clinically normal cattle, but they may be detected in the
pathogenesis of other respiratory tract diseases (1, 29). Besides
the 18 normal control cattle of this report, 20 normal cattle and
32 cattle with chronic lungworm infections did not shed RBCV
in nasal secretions in related investigations (29, 30). (v) Cattle
with significant antibody titers against the candidate virus do
not develop SFP, which occurs in cattle without such immune
protection. Eighteen normal control cattle remaining clinically
healthy and RBCV isolation negative (7 in 1997 and 11 in
1998) had significant titers of HAI antibodies against RBCV at
the beginning of the epizootics. These cattle had the highest
levels of total and IgG2 antibodies against RBCV (20, 21). In
contrast, calves without such immune protections developed
acute respiratory tract disease, including the fatal cases de-
scribed above. (vi) Elimination of the virus factor prevents or
decreases the severity of SFP. This criterion awaits the devel-
opment of an effective vaccine. (vii) “The whole thing should
make biologic and epidemiologic sense” (7, 32). The virologi-
cal, bacteriological, immunological, epidemiological, patholog-
ical, and histological findings on cattle of these two experimen-
tally monitored epizootics of SFP satisfy this criterion to a full
measure.
Application of these criteria to virus infections of the two
epizootics identifies RBCV in these fatal cases of SFP as an
initiating and significant infection that was previously not rec-
ognized. This report describes for the first time initial high
rates of respiratory tract infections with a virus and the evolv-
ing secondary infections with Pasteurella spp. among cattle
developing fatal SFP under experimentally controlled condi-
tions in natural settings of two severe epizootics.
The initial high rates of nasal RBCV shedding followed by
lung infections with RBCV and P. haemolytica or P. multocida
were proven through cultivation and quantification of these
infectious agents in nasal secretions and affected lungs. The
fatal outcomes of the combined infections of lungs with RBCV
and Pasteurella spp. probably were influenced by the bacterial
component which induced necrotizing lesions in the lungs.
Importantly, normal control cattle that remained healthy and
were refractile to infectious insults entered the evolving
epizootics with significant HAI antibody titers to RBCV, and
they mounted antibody responses to antigens of P. haemolytica
within 5 days.
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